| 20 Aug 2026, 03:24 | Appendix 4E and Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 |
| 19 Aug 2026, 21:38 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 |
| 19 Aug 2026, 21:33 | Appendix 4E and Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 |
| 15 Aug 2026, 00:46 | Application for quotation of securities - PER | Other | — | 06020 |
| 12 Aug 2026, 18:16 | Notice of date of AGM and other relevant dates | Meetings & Governance | — | 08006 |
| 10 Aug 2026, 18:24 | Percheron Therapeutics Announces CEO Succession | Other | MS | 12019 |
| 31 July 2026, 18:29 | Quarterly Activities Report and Appendix 4C | Quarterly Reports | MS | 19004, 19009 |
| 4 July 2026, 02:21 | Notification regarding unquoted securities - PER | Other | — | 06021 |
| 17 June 2026, 18:22 | Completion of HMBD-002 Drug Substance Manufacture | Company Update | — | 11001 |
| 2 June 2026, 18:22 | New HMBD-002 Data Presented at ASCO Annual Meeting | Company Update | — | 11001 |
| 2 June 2026, 01:41 | Notification regarding unquoted securities - PER | Other | — | 06021 |
| 29 May 2026, 21:26 | Proposed issue of securities - PER | Securities Administration | — | 06013 |
| 26 May 2026, 19:22 | WHO selects proposed INN for HMBD-002 | Company Update | — | 11001 |
| 1 May 2026, 18:15 | Notification of cessation of securities - PER | Other | — | 06027 |
| 30 Apr 2026, 18:57 | Quarterly Activities Report and Appendix 4C | Quarterly Reports | MS | 19003, 19008 |
| 22 Apr 2026, 19:20 | Notification regarding unquoted securities - PER | Other | — | 06021 |
| 22 Apr 2026, 19:17 | Application for quotation of securities - PER | Other | — | 06020 |
| 21 Apr 2026, 18:17 | New HMBD-002 Data Presented at AACR Annual Meeting | Company Administration | — | 12008 |
| 15 Apr 2026, 21:52 | Update - Notification regarding unquoted securities - PER | Other | — | 06021 |
| 15 Apr 2026, 21:51 | Update - Notification regarding unquoted securities - PER | Other | — | 06021 |
| 15 Apr 2026, 21:27 | Notification regarding unquoted securities - PER | Other | — | 06021 |
| 15 Apr 2026, 21:25 | Notification regarding unquoted securities - PER | Other | — | 06021 |
| 15 Apr 2026, 21:24 | Change of Director's Interest Notice | Director Interests | — | 02009 |
| 15 Apr 2026, 21:18 | Notification regarding unquoted securities - PER | Other | — | 06021 |
| 15 Apr 2026, 21:10 | Application for quotation of securities - PER | Other | — | 06020 |
| 14 Apr 2026, 23:00 | Results of Entitlement Offer | Capital Raising | MS | 06008 |
| 2 Apr 2026, 20:47 | Non-renounceable Entitlement Offer Closing Date Reminder | Capital Raising | — | 06008 |
| 31 Mar 2026, 19:22 | New HMBD-002 Preclinical Data to be Presented at ASCO | Company Update | — | 11001 |
| 24 Mar 2026, 19:18 | Letter to Ineligible Shareholders | Capital Raising | — | 06008, 16002 |
| 24 Mar 2026, 19:18 | Letter to Eligible Shareholders | Capital Raising | — | 06008, 16002 |
| 24 Mar 2026, 19:17 | Non-renounceable Entitlement Offer Opens | Capital Raising | — | 06008 |
| 16 Mar 2026, 23:45 | Letter to option holders | Capital Raising | — | 06008, 16002 |
| 16 Mar 2026, 23:41 | Proposed issue of securities - PER | Securities Administration | — | 06013 |
| 16 Mar 2026, 23:29 | Proposed issue of securities - PER | Securities Administration | — | 06013 |
| 16 Mar 2026, 23:18 | Non-renounceable Entitlement Offer - Amended Timetable | Capital Raising | — | 06008 |
| 16 Mar 2026, 21:01 | Prospectus - Non-renounceable Entitlement Offer | Capital Raising | MS | 06008, 06010 |
| 16 Mar 2026, 20:59 | Non-renounceable Entitlement Offer | Capital Raising | MS | 06008 |
| 14 Mar 2026, 05:22 | Proposed issue of securities - PER | Securities Administration | — | 06013 |
| 26 Feb 2026, 23:41 | Half Yearly Report and Accounts | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 |
| 19 Feb 2026, 19:09 | Percheron to Present at the 2026 AACR Annual Meeting | Company Administration | — | 12008 |
| 18 Feb 2026, 19:15 | Percheron Therapeutics Limited - Corporate Presentation | Presentations | — | 03026 |
| 30 Jan 2026, 19:46 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19002, 19007 |
| 30 Dec 2025, 20:16 | Change of Director's Interest Notice - Dr Ben Gil Price | Director Interests | — | 02009 |
| 23 Dec 2025, 20:57 | Change of Director's Interest Notice - Dr James Garner | Director Interests | — | 02009 |
| 5 Nov 2025, 19:37 | Percheron Therapeutics Limited Corporate Presentation | Presentations | — | 03026 |
| 31 Oct 2025, 19:57 | Quarterly Activities Report and Appendix 4C | Quarterly Reports | MS | 19001, 19006 |
| 22 Oct 2025, 23:47 | Results of Annual General Meeting | Meetings & Governance | — | 08003 |
| 22 Oct 2025, 20:47 | Annual General Meeting - Management Presentation | Presentations | — | 03026, 15002 |
| 22 Oct 2025, 20:45 | Annual General Meeting - Chair's Address | Letters & Addresses | — | 15002 |
| 7 Oct 2025, 19:23 | HMBD-002 Phase I Clinical Trial - Webinar Presentation | Presentations | — | 03026 |